Investigation of antioxidant and anticonvulsant activity of Hypericum triquetrifolium Turra

Abstract

Epilepsy is a state characterized by sudden, recurrent epileptic seizures that are not initiated by an identifiable event. There are various studies has been shown that Hypericum species may be used for their anticonvulsant potentials. Besides, the relationship between anticonvulsant activity and antioxidant effect has already been shown in the literature. In the current study, H. triquetrifolium was investigated for the first time for its potential antioxidant and anticonvulsant potential using in vitro and in vivo test models. H. triquetrifolium extracts were tested with DPPH assay, FRAP assay, copper (II) ion reducing antioxidant capacity assay, and acetylcholinesterase inhibitory activity assay to understand their antioxidant potential. Especially, methanolic extract of H. triquetrifolium was shown the highest antioxidant activity. Moreover, a pentylenetetrazole (PTZ, 80 mg/kg, i.p.)-induced seizure model was conducted to analyze the anticonvulsant activities of H. triquetrifolium extracts in mice. In addition, this study revealed that H. triquetrifolium decreased the ratio of severe seizures and increased the mean onsite of mortality and survival rate in a dose-dependent manner. It is thought that the anticonvulsant effect may be either related to the antioxidant potential of H. triquetrifolium or its interference in the GABAergic system.

Keywords

• Hypericum triquetrifolium Turra
• antioxidant activity
• anticonvulsant activity
• epilepsy
• Hypericaceae

References

1. [1] Crockett SL, Robson NKB. Taxonomy and Chemotaxonomy of the Genus Hypericum. Med Aromat Plant Sci Biotechnol 2011;5:1–13.
2. [2] Zhang R, Ji Y, Zhang X, Kennelly EJ, Long C. Ethnopharmacology of Hypericum species in China: A comprehensive review on ethnobotany, phytochemistry and pharmacology. J Ethnopharmacol 2020;254:112686. [CrossRef]
3. [3] Crockett S, Eberhardt M, Kunert O, Schühly W. Hypericum species in the Páramos of Central and South America: a special focus upon H. irazuense Kuntze ex N. Robson. Phytochem Rev 2010;9:255–69. [CrossRef]
4. [4] Özkan EE, Mat A. An overview on Hypericum species of Turkey. J Pharmacogn Phyther 2013;5:38–46. [CrossRef]
5. [5] Bingol U, Cosge B, Gurbuz B. Hypericum Species in the Flora of Turkey. Med Aromat Plant Sci Biotechnol 2011;5:86–90.
6. [6] Norman K.B. Robson (2002). Studies in the genus Hypericum L. (Guttiferae) 4(2). Section 9. Hypericum sensu lato (part 2): subsection 1. Hypericum series 1. Hypericum. Bulletin of the Natural History Museum: Botany, 32, pp 61–123. [CrossRef]
7. [7] Çirak C, Radušiene J, Janulis V, Ivanauskas L, Çamaş N, Ayan AK. Phenolic constituents of Hypericum triquetrifolium Turra (Guttiferae) growing in Turkey: Variation among populations and plant parts. Turkish J Biol 2011;35:449–56. [CrossRef]
8. [8] Baytop T. Turkiye’de Bitkiler ile Tedavi (Phytotherapy in Turkey, Past and Present). Istanbul: Nobel Publishers; 1999.

9. [9] Pistelli L, Bertoli A, Morelli I, Menichini F, Musmanno RA, Di Maggio T, et al. Chemical and antibacterial evaluation of Hypericum triquetrifolium Turra. Phyther Res 2005;19:787–91. [CrossRef]
10. [10] Ozturk B, Apaydin S, Goldeli E, Ince I, Zeybek U. Hypericum triquetrifolium Turra. extract exhibits antiinflammatory activity in the rat. J Ethnopharmacol 2002;80:207–9. [CrossRef]
11. [11] Conforti F, Loizzo MR, Statti AG, Menichini F. Cytotoxic activity of antioxidant constituents from Hypericum triquetrifolium Turra. Nat Prod Res 2007;21:42–6. doi:10.1080/14786410500356243. [CrossRef]
12. [12] Apaydın S, Zeybek U, Ince I, Elgin G, Karamenderes C, Ozturk B, et al. Hypericum triquetrifolium Turra. extract exhibits antinociceptive activity in the mouse. J Ethnopharmacol 1999;67:307–12. [CrossRef]
13. [13] Dall’Acqua S, Ak G, Sinan KI, Elbasan F, Ferrarese I, Sut S, et al. Hypericum triquetrifolium and H. neurocalycinum as Sources of Antioxidants and Multi-Target Bioactive Compounds: A Comprehensive Characterization Combining In Vitro Bioassays and Integrated NMR and LC-MS Characterization by Using a Multivariate Approach. Front Pharmacol 2021;12:660735. [CrossRef]
14. [14] Sørensen AT, Kokaia M. Novel approaches to epilepsy treatment. Epilepsia 2013;54:1–10. doi:10.1111/epi.12000. [CrossRef]
15. [15] Duncan JS, Sander JW, Sisodiya S, Walker M. Adult Epilepsy. Lancet 2006;367:1087–100. [CrossRef]
16. [16] World Health Organization. Epilepsy Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/epilepsy Date of Access: [02.02.21]
17. [17] Ebrahimzadeh MA, Nabavi SM, Nabavi SF, Ahangar N. Anticonvulsant activity of Hypericum scabrum L.; Possible mechanism involved. Eur Rev Med Pharmacol Sci 2013;17:2141–4.
18. [18] Hosseinzadeh H, Karimi GR, Rakhshanizadeh M. Anticonvulsant effect of Hypericum perforatum: Role of nitric oxide. J Ethnopharmacol 2005;98:207–8. [CrossRef]
19. [19] Aguiar CCT, Almeida AB, Arajo PVP, Abreu RNDC De, Chaves EMC, Vale OC Do, et al. Oxidative stress and epilepsy: Literature review. Oxid Med Cell Longev 2012;2012:795259. [CrossRef]
20. [20] Patel M. Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic Biol Med 2004;37:1951–62. [CrossRef]
21. [21] Kessler RC, Amminger GP, Aguilar-Gaxiola S, Alonso J, Lee S, Ustun TB. Age of onset of mental disorders: A review of recent literature. Curr Opin Psychiatry 2007;20:359–64. [CrossRef]
22. [22] Alzoubi KH, Abdel-Hafiz L, Khabour OF, El-Elimat T, Alzubi MA, Alali FQ. Evaluation of the effect of Hypericum triquetrifolium turra on memory impairment induced by chronic psychosocial stress in rats: Role of BDNF. Drug Des Devel Ther 2020;14:5299–314. [CrossRef]
23. [23] Zirak N, Shafiee M, Soltani G, Mirzaei M, Sahebkar A. Hypericum perforatum in the treatment of psychiatric and neurodegenerative disorders: Current evidence and potential mechanisms of action. J Cell Physiol 2019;234:8496–508. [CrossRef]
24. [24] Oliveira AI, Pinho C, Sarmento B, Dias ACP. Neuroprotective activity of Hypericum perforatum and its major components. Front Plant Sci 2016;7:1004. [CrossRef]
25. [25] Ivetic V, Trivic S, Pogancev MK, Popovic M, Zlinská J. Effects of St John’s wort (Hypericum perforatum L.) extracts on epileptogenesis. Molecules 2011;16:8062–75. [CrossRef]
26. [26] De Sarro A, Cecchetti V, Fravolini V, Naccari F, Tabarrini O, De Sarro G. Effects of novel 6-desfluoroquinolones and classic quinolones on pentylenetetrazole-induced seizures in mice. Antimicrob Agents Chemother 1999;43:1729–36. [CrossRef]
27. [27] Fu W, Chen J, Cai Y, Lei Y, Chen L, Pei L, et al. Antioxidant, free radical scavenging, anti-inflammatory and hepatoprotective potential of the extract from Parathelypteris nipponica (Franch. et Sav.) Ching. J Ethnopharmacol 2010;130:521–8. [CrossRef]
28. [28] Benzie I, Strain JJ. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of ‘“Antioxidant Power”’: The FRAP Assay. Anal Biochem 1996;239:70–6. [CrossRef]
29. [29] Apak R, Güçlü K, Özyürek M, Karademir SE. Novel total antioxidant capacity index for dietary polyphenols and vitamins C and E, using their cupric ion reducing capability in the presence of neocuproine: CUPRAC method. J Agric Food Chem 2004;52:7970–81. [CrossRef]
30. [30] Ellman GL, Courtney KD, Andres V, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
31. [31] Bhat MA, Al-Omar MA. Coumarin incorporated triazoles: A new class of anticonvulsants. Acta Pol Pharm - Drug Res 2011;68:889–95.
32. [32] Faiz Arshad M, Siddiqui N, Elkerdasy A, Al Rohaimi AH, Khan SA. Anticonvulsant and neurotoxicity evaluation of some newly synthesized thiazolyl coumarin derivatives. Am J Pharmacol Toxicol 2014;9:132–8. [CrossRef]
33. [33] Kamiński K, Socała K, Zagaja M, Andres-Mach M, Abram M, Jakubiec M, et al. N-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug. Neurotherapeutics 2020;17:309–28. [CrossRef]
34. [34] Keshavarz M, Yekzaman B. Amelioration of pentylenetetrazole-induced seizures by modulators of sigma, N-methyl-D-aspartate, and ryanodine receptors in mice. Iran J Med Sci 2018;43:195–201.
35. [35] Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949;96:99–113.
36. [36] Pithadia AB, Navale A, Mansuri J, Shetty RS, Panchal S, Goswami S. Reversal of experimentally induced seizure activity in mice by glibenclamide. Ann Neurosci 2013;20:10–2. [CrossRef]
37. [37] Khoshnood-Mansoorkhani MJ, Moein MR, Oveisi N. Anticonvulsant activity of teucrium polium against seizure induced by PTZ and MES in mice. Iran J Pharm Res 2010;9:395–401. [CrossRef]
38. [38] Racine RJ. Modification of seizure activity by electrical stimulation. I. After-discharge threshold. Electroencephalogr Clin Neurophysiol 1972;32:269–79. [CrossRef]